ClinicalTrials.gov record
A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment
COMPLETED · NCT05857124
Trial record
NCT IDNCT05857124
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE1
Enrollment
36
Conditions
Post COVID-19 Cognitive Impairment
Interventions
Vielight Neuro RX Gamma active device, Vielight Neuro RX Gamma sham device
Locations
Ascada Research, Fullerton, California, United States
Indexed topics
Last update
2025-06-10